Aurenar
4 known investors
Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients. The device aims to improve patient outcomes, reduce hospital length of stay, and lower the cost of ICU care.
Founders & leadership
Investors · 4
Kaleida CapitalSan Diegovia Ariane Tom · led
Deep FuturereportedSeattlevia Pablos Holman · inferred
Solas BioVenturesreported · 2 sourcesChattanooga
Also in the syndicate · 1
Go Red for Women Venture Fund™lead
Funding
SEC filings, press & company announcements- Undisclosed amountSeed RoundJul 2026
Go Red for Women Venture Fund™ (lead), Solas BioVentures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Aurenar do?
- Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients. The device aims to improve patient outcomes, reduce hospital length of stay, and lower the cost of ICU care.
- Who founded Aurenar?
- Aurenar was founded by Eric Leuthardt, Jenna Gorlewicz, Anna Huguenard.
- Who are Aurenar's investors?
- Aurenar's investors include Kaleida Capital, Deep Future, Solas BioVentures.